OptiNose (OPTN) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseZacks Investment Research • 02/23/22
After Plunging 44.2% in 4 Weeks, Here's Why the Trend Might Reverse for OptiNose (OPTN)Zacks Investment Research • 11/22/21
OptiNose, Inc. (OPTN) CEO Peter Miller on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/16/21
Optinose Reports Third Quarter 2021 Financial Results and Recent Operational HighlightsGlobeNewsWire • 11/15/21
Will OptiNose (OPTN) Report Negative Q3 Earnings? What You Should KnowZacks Investment Research • 10/28/21
Optinose Completes Patient Recruitment in Second Pivotal Trial for XHANCE in Chronic SinusitisGlobeNewsWire • 10/28/21
OptiNose, Inc. (OPTN) CEO Peter Miller on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/11/21
Optinose Reports Second Quarter 2021 Financial Results and Recent Operational HighlightsGlobeNewsWire • 08/11/21
Optinose Completes Patient Recruitment in Pivotal Trial for XHANCE in Chronic SinusitisGlobeNewsWire • 07/30/21